Details for Patent: 8,058,267
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 8,058,267 protect, and when does it expire?
Patent 8,058,267 protects OCALIVA and is included in one NDA.
This patent has sixteen patent family members in twelve countries.
Summary for Patent: 8,058,267
Title: | Steroids as agonists for FXR |
Abstract: | The invention relates to compounds of formula (I): ##STR00001## wherein R is ethyl and pharmaceutically acceptable salts, solvates or amino acid conjugates thereof. The compounds of formula (I) are useful as FXR agonists. |
Inventor(s): | Pellicciari; Roberto (Perugia, IT) |
Assignee: | Intercept Pharmaceuticals, Inc. (New York, NY) |
Application Number: | 12/547,147 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,058,267
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intercept Pharms Inc | OCALIVA | obeticholic acid | TABLET;ORAL | 207999-001 | May 27, 2016 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | TREATMENT OF PRIMARY BILIARY CHOLANGITIS (PBC) | See Plans and Pricing | ||||
Intercept Pharms Inc | OCALIVA | obeticholic acid | TABLET;ORAL | 207999-002 | May 27, 2016 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | TREATMENT OF PRIMARY BILIARY CHOLANGITIS (PBC) | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,058,267
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 303399 | See Plans and Pricing | |||
Australia | 2002308295 | See Plans and Pricing | |||
Canada | 2440680 | See Plans and Pricing | |||
Germany | 60205891 | See Plans and Pricing | |||
Denmark | 1392714 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |